September 2012 Briefing - HIV & AIDSLast Updated: October 01, 2012.
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for September 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
HIV Outcomes Similar Across Groups in Inner-City Clinic
FRIDAY, Sept. 28 (HealthDay News) -- HIV health processes and outcomes are similar for all demographic and behavioral groups, according to a study published online Sept. 26 in Clinical Infectious Diseases.
Not All Docs/Nurses Want to Be Asked About Hand Hygiene
FRIDAY, Sept. 7 (HealthDay News) -- Although most health care workers (HCWs) appreciate the role of patients in preventing health care-associated infection, a considerable proportion are uncomfortable with patients asking about their hand hygiene, according to a letter published online Sept. 3 in the Archives of Internal Medicine.
Antiretrovirals Increasingly Used for HIV in the U.S.
FRIDAY, Sept. 7 (HealthDay News) -- Since 2000, more HIV-infected patients in the United States are receiving antiretroviral treatment, viral load has fallen, and CD4 counts at death have risen, according to a study published in the Sept. 4 issue of the Annals of Internal Medicine.
|Previous: September 2012 Briefing - Gastroenterology||Next: September 2012 Briefing - Infectious Disease|
Reader comments on this article are listed below. Review our comments policy.